EligibleTrials

Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease

Recruiting · NCT02740868 · Interventional (participants receive a specific treatment) · Lead sponsor: The Hospital for Sick Children

View the official record on ClinicalTrials.gov →
Asthma

Interventions studied

Lung Clearance IndexMagnetic Resonance ImagingXenon-129 and Perfluoropropane (19F)

What this trial is about

Aim of this study is to evaluate image quality and reproducibility of Xenon-129 and Inert fluorinated (19F) gas Magnetic Resonance Imaging (MRI) and to evaluate changes in lung structure and function in participants with cystic fibrosis (CF) and asthma compared to healthy controls.

Who can take part

Age range
8 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.